These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

633 related articles for article (PubMed ID: 27296412)

  • 1. CT-based radiomic analysis of stereotactic body radiation therapy patients with lung cancer.
    Huynh E; Coroller TP; Narayan V; Agrawal V; Hou Y; Romano J; Franco I; Mak RH; Aerts HJ
    Radiother Oncol; 2016 Aug; 120(2):258-66. PubMed ID: 27296412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations of Radiomic Data Extracted from Static and Respiratory-Gated CT Scans with Disease Recurrence in Lung Cancer Patients Treated with SBRT.
    Huynh E; Coroller TP; Narayan V; Agrawal V; Romano J; Franco I; Parmar C; Hou Y; Mak RH; Aerts HJ
    PLoS One; 2017; 12(1):e0169172. PubMed ID: 28046060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiomics-based Assessment of Radiation-induced Lung Injury After Stereotactic Body Radiotherapy.
    Moran A; Daly ME; Yip SSF; Yamamoto T
    Clin Lung Cancer; 2017 Nov; 18(6):e425-e431. PubMed ID: 28623121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pretreatment
    Dissaux G; Visvikis D; Da-Ano R; Pradier O; Chajon E; Barillot I; Duvergé L; Masson I; Abgral R; Santiago Ribeiro MJ; Devillers A; Pallardy A; Fleury V; Mahé MA; De Crevoisier R; Hatt M; Schick U
    J Nucl Med; 2020 Jun; 61(6):814-820. PubMed ID: 31732678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application and limitation of radiomics approach to prognostic prediction for lung stereotactic body radiotherapy using breath-hold CT images with random survival forest: A multi-institutional study.
    Kakino R; Nakamura M; Mitsuyoshi T; Shintani T; Kokubo M; Negoro Y; Fushiki M; Ogura M; Itasaka S; Yamauchi C; Otsu S; Sakamoto T; Sakamoto M; Araki N; Hirashima H; Adachi T; Matsuo Y; Mizowaki T
    Med Phys; 2020 Sep; 47(9):4634-4643. PubMed ID: 32645224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CT imaging features associated with recurrence in non-small cell lung cancer patients after stereotactic body radiotherapy.
    Li Q; Kim J; Balagurunathan Y; Qi J; Liu Y; Latifi K; Moros EG; Schabath MB; Ye Z; Gillies RJ; Dilling TJ
    Radiat Oncol; 2017 Sep; 12(1):158. PubMed ID: 28946909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiomic analysis of planning computed tomograms for predicting radiation-induced lung injury and outcome in lung cancer patients treated with robotic stereotactic body radiation therapy.
    Bousabarah K; Temming S; Hoevels M; Borggrefe J; Baus WW; Ruess D; Visser-Vandewalle V; Ruge M; Kocher M; Treuer H
    Strahlenther Onkol; 2019 Sep; 195(9):830-842. PubMed ID: 30874846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of pre-treatment radiomic features with lung cancer recurrence following stereotactic body radiation therapy.
    Lafata KJ; Hong JC; Geng R; Ackerson BG; Liu JG; Zhou Z; Torok J; Kelsey CR; Yin FF
    Phys Med Biol; 2019 Jan; 64(2):025007. PubMed ID: 30524018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CT-based radiomic signature predicts distant metastasis in lung adenocarcinoma.
    Coroller TP; Grossmann P; Hou Y; Rios Velazquez E; Leijenaar RT; Hermann G; Lambin P; Haibe-Kains B; Mak RH; Aerts HJ
    Radiother Oncol; 2015 Mar; 114(3):345-50. PubMed ID: 25746350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Homology-based radiomic features for prediction of the prognosis of lung cancer based on CT-based radiomics.
    Kadoya N; Tanaka S; Kajikawa T; Tanabe S; Abe K; Nakajima Y; Yamamoto T; Takahashi N; Takeda K; Dobashi S; Takeda K; Nakane K; Jingu K
    Med Phys; 2020 Jun; 47(5):2197-2205. PubMed ID: 32096876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of optimal mother wavelets in survival prediction of lung cancer patients using wavelet decomposition-based radiomic features.
    Soufi M; Arimura H; Nagami N
    Med Phys; 2018 Nov; 45(11):5116-5128. PubMed ID: 30230556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiomic phenotype features predict pathological response in non-small cell lung cancer.
    Coroller TP; Agrawal V; Narayan V; Hou Y; Grossmann P; Lee SW; Mak RH; Aerts HJ
    Radiother Oncol; 2016 Jun; 119(3):480-6. PubMed ID: 27085484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Classification of early stage non-small cell lung cancers on computed tomographic images into histological types using radiomic features: interobserver delineation variability analysis.
    Haga A; Takahashi W; Aoki S; Nawa K; Yamashita H; Abe O; Nakagawa K
    Radiol Phys Technol; 2018 Mar; 11(1):27-35. PubMed ID: 29209915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of texture-based radiomics CT analysis to predict outcomes in early-stage non-small cell lung cancer treated with stereotactic ablative radiotherapy.
    Starkov P; Aguilera TA; Golden DI; Shultz DB; Trakul N; Maxim PG; Le QT; Loo BW; Diehn M; Depeursinge A; Rubin DL
    Br J Radiol; 2019 Feb; 92(1094):20180228. PubMed ID: 30457885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integration of Risk Survival Measures Estimated From Pre- and Posttreatment Computed Tomography Scans Improves Stratification of Patients With Early-Stage Non-small Cell Lung Cancer Treated With Stereotactic Body Radiation Therapy.
    Jiao Z; Li H; Xiao Y; Aggarwal C; Galperin-Aizenberg M; Pryma D; Simone CB; Feigenberg SJ; Kao GD; Fan Y
    Int J Radiat Oncol Biol Phys; 2021 Apr; 109(5):1647-1656. PubMed ID: 33333202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imaging features from pretreatment CT scans are associated with clinical outcomes in nonsmall-cell lung cancer patients treated with stereotactic body radiotherapy.
    Li Q; Kim J; Balagurunathan Y; Liu Y; Latifi K; Stringfield O; Garcia A; Moros EG; Dilling TJ; Schabath MB; Ye Z; Gillies RJ
    Med Phys; 2017 Aug; 44(8):4341-4349. PubMed ID: 28464316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multicentric development and evaluation of [
    Lucia F; Louis T; Cousin F; Bourbonne V; Visvikis D; Mievis C; Jansen N; Duysinx B; Le Pennec R; Nebbache M; Rehn M; Hamya M; Geier M; Salaun PY; Schick U; Hatt M; Coucke P; Hustinx R; Lovinfosse P
    Eur J Nucl Med Mol Imaging; 2024 Mar; 51(4):1097-1108. PubMed ID: 37987783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the performance of both machine learning models using PET and CT radiomics for predicting recurrence following lung stereotactic body radiation therapy: A single-institutional study.
    Nemoto H; Saito M; Satoh Y; Komiyama T; Marino K; Aoki S; Suzuki H; Sano N; Nonaka H; Watanabe H; Funayama S; Onishi H
    J Appl Clin Med Phys; 2024 Jul; 25(7):e14322. PubMed ID: 38436611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A radiomic approach to predicting nodal relapse and disease-specific survival in patients treated with stereotactic body radiation therapy for early-stage non-small cell lung cancer.
    Franceschini D; Cozzi L; De Rose F; Navarria P; Fogliata A; Franzese C; Pezzulla D; Tomatis S; Reggiori G; Scorsetti M
    Strahlenther Onkol; 2020 Oct; 196(10):922-931. PubMed ID: 31722061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FDG PET/CT texture analysis for predicting the outcome of lung cancer treated by stereotactic body radiation therapy.
    Lovinfosse P; Janvary ZL; Coucke P; Jodogne S; Bernard C; Hatt M; Visvikis D; Jansen N; Duysinx B; Hustinx R
    Eur J Nucl Med Mol Imaging; 2016 Jul; 43(8):1453-60. PubMed ID: 26830299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.